| COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study VJ Hall, S Foulkes, A Saei, N Andrews, B Oguti, A Charlett, E Wellington, ... The Lancet 397 (10286), 1725-1735, 2021 | 759 | 2021 |
| SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) VJ Hall, S Foulkes, A Charlett, A Atti, EJM Monk, R Simmons, E Wellington, ... The Lancet 397 (10283), 1459-1469, 2021 | 672 | 2021 |
| Use of hydrogen peroxide as a biocide: new consideration of its mechanisms of biocidal action E Linley, SP Denyer, G McDonnell, C Simons, JY Maillard Journal of antimicrobial Chemotherapy 67 (7), 1589-1596, 2012 | 594 | 2012 |
| Protection against SARS-CoV-2 after Covid-19 vaccination and previous infection V Hall, S Foulkes, F Insalata, P Kirwan, A Saei, A Atti, E Wellington, ... New England Journal of Medicine 386 (13), 1207-1220, 2022 | 539 | 2022 |
| Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection J Zuo, AC Dowell, H Pearce, K Verma, HM Long, J Begum, F Aiano, ... Nature immunology 22 (5), 620-626, 2021 | 411 | 2021 |
| Mode of action of hydrogen peroxide and other oxidizing agents: differences between liquid and gas forms M Finnegan, E Linley, SP Denyer, G McDonnell, C Simons, JY Maillard Journal of Antimicrobial Chemotherapy 65 (10), 2108-2115, 2010 | 385 | 2010 |
| Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection AC Dowell, MS Butler, E Jinks, G Tut, T Lancaster, P Sylla, J Begum, ... Nature immunology 23 (1), 40-49, 2022 | 167 | 2022 |
| Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groups HJ Whitaker, RSM Tsang, R Byford, NJ Andrews, J Sherlock, PS Pillai, ... Journal of Infection 84 (5), 675-683, 2022 | 115 | 2022 |
| Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England G Amirthalingam, JL Bernal, NJ Andrews, H Whitaker, C Gower, J Stowe, ... Nature Communications 12 (1), 7217, 2021 | 100 | 2021 |
| SARS-CoV-2 infection and transmission in primary schools in England in June–December, 2020 (sKIDs): an active, prospective surveillance study SN Ladhani, F Baawuah, J Beckmann, IO Okike, S Ahmad, J Garstang, ... The Lancet Child & Adolescent Health 5 (6), 417-427, 2021 | 95 | 2021 |
| Emergence of a novel coronavirus (COVID-19): protocol for extending surveillance used by the Royal College of General Practitioners Research and Surveillance Centre and Public … S de Lusignan, JL Bernal, M Zambon, O Akinyemi, G Amirthalingam, ... JMIR public health and surveillance 6 (2), e18606, 2020 | 92 | 2020 |
| Serological surveillance of SARS-CoV-2: Six-month trends and antibody response in a cohort of public health workers RJ Harris, HJ Whitaker, NJ Andrews, F Aiano, Z Amin-Chowdhury, J Flood, ... Journal of Infection 82 (5), 162-169, 2021 | 84 | 2021 |
| Use of dried blood spot samples for SARS-CoV-2 antibody detection using the Roche Elecsys® high throughput immunoassay R Mulchandani, B Brown, T Brooks, A Semper, N Machin, E Linley, ... Journal of Clinical Virology 136, 104739, 2021 | 47 | 2021 |
| Should pneumococcal serotype 3 be included in serotype-specific immunoassays? E Linley, A Bell, JF Gritzfeld, R Borrow Vaccines 7 (1), 4, 2019 | 43 | 2019 |
| The role of the exosporium in the environmental distribution of anthrax G Williams, E Linley, R Nicholas, L Baillie Journal of Applied Microbiology 114 (2), 396-403, 2013 | 34 | 2013 |
| Characterising long COVID more than 6 months after acute infection in adults; prospective longitudinal cohort study, England Z Amin-Chowdhury, RJ Harris, F Aiano, M Zavala, M Bertran, R Borrow, ... medRxiv, 2021.03. 18.21253633, 2021 | 30 | 2021 |
| Haemophilus influenzae type b (Hib) seroprevalence and current epidemiology in England and Wales S Collins, D Litt, R Almond, J Findlow, E Linley, M Ramsay, R Borrow, ... Journal of Infection 76 (4), 335-341, 2018 | 30 | 2018 |
| Seroprevalence of SARS-CoV-2 antibodies in university students: Cross-sectional study, December 2020, England A Vusirikala, H Whitaker, S Jones, E Tessier, R Borrow, E Linley, ... Journal of Infection 83 (1), 104-111, 2021 | 29 | 2021 |
| Emergence of SARS-CoV-2 Alpha (B. 1.1. 7) variant, infection rates, antibody seroconversion and seroprevalence rates in secondary school students and staff: Active prospective … SN Ladhani, G Ireland, F Baawuah, J Beckmann, IO Okike, S Ahmad, ... Journal of Infection 83 (5), 573-580, 2021 | 27 | 2021 |
| Serogroup C Neisseria meningitidis disease epidemiology, seroprevalence, vaccine effectiveness and waning immunity, England, 1998/99 to 2015/16 H Findlow, H Campbell, J Lucidarme, N Andrews, E Linley, S Ladhani, ... Eurosurveillance 24 (1), 1700818, 2019 | 27 | 2019 |
